Literature DB >> 19000153

Disseminated tuberculosis following second unrelated cord blood transplantation for acute myelogenous leukemia.

T Shima1, G Yoshimoto, T Miyamoto, S Yoshida, K Kamezaki, K Takenaka, H Iwasaki, N Harada, K Nagafuji, T Teshima, N Shimono, K Akashi.   

Abstract

Here we report the case of a 43-year-old Japanese woman with acute myelogenous leukemia who underwent 2 unrelated cord blood transplantations (UCBT), terminating in fatal disseminated tuberculosis (TB). The patient did not achieve remission despite intensive chemotherapy, and subsequently underwent UCBT with a standard conditioning regimen. However, engraftment was not achieved. Fifty days after the first UCBT, the patient underwent a second UCBT with a reduced-intensity conditioning regimen. She developed a pre-engraftment immune reaction, which responded well to prednisolone, and engraftment was documented. However, 50 days after the second UCBT, the patient presented with high fever and developed pneumonia despite antibiotic and antifungal treatments. Thereafter, Mycobacterium tuberculosis was detected in blood cultures and specimens of bronchoalveolar lavage, thus indicating disseminated TB. Despite anti-tuberculous treatment, she died on day 85. TB should always be considered as a possible diagnosis when treating febrile immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000153     DOI: 10.1111/j.1399-3062.2008.00354.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.

Authors:  J Zhang; M Mosunjac; A Moon; A Nooka; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

2.  A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.

Authors:  W Lam; A Viswabandya; S Hussain; H A Messner; F V Michelis; D D Kim; J H Lipton; U Deotare
Journal:  Bone Marrow Transplant       Date:  2016-05-16       Impact factor: 5.483

Review 3.  Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma Marzouq Al-Jasser; Khalid Alsaleh
Journal:  Front Oncol       Date:  2014-08-26       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.